Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of MXN 2.58 trillion. The enterprise value is 3.47 trillion.

Market Cap	2.58T
Enterprise Value	3.47T

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 16.01 and the forward PE ratio is 8.05.

PE Ratio	16.01
Forward PE	8.05
PS Ratio	2.02
PB Ratio	1.39
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.16, with an EV/FCF ratio of 15.13.

EV / Earnings	21.54
EV / Sales	2.83
EV / EBITDA	7.16
EV / EBIT	10.62
EV / FCF	15.13

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.69.

Current Ratio	1.26
Quick Ratio	0.88
Debt / Equity	0.69
Debt / EBITDA	2.55
Debt / FCF	5.56
Interest Coverage	5.57

Financial Efficiency

Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.52%.

Return on Equity (ROE)	8.62%
Return on Assets (ROA)	4.79%
Return on Invested Capital (ROIC)	6.52%
Return on Capital Employed (ROCE)	9.58%
Revenue Per Employee	15.75M
Profits Per Employee	1.99M
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.45% in the last 52 weeks. The beta is 0.50, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-7.45%
50-Day Moving Average	488.71
200-Day Moving Average	534.39
Relative Strength Index (RSI)	43.79
Average Volume (20 Days)	15,323

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.15

Income Statement

In the last 12 months, Pfizer had revenue of MXN 1.28 trillion and earned 161.05 billion in profits. Earnings per share was 28.26.

Revenue	1.28T
Gross Profit	949.75B
Operating Income	335.97B
Pretax Income	150.90B
Net Income	161.05B
EBITDA	476.45B
EBIT	335.97B
Earnings Per Share (EPS)	28.26

Full Income Statement

Balance Sheet

The company has 353.83 billion in cash and 1.27 trillion in debt, giving a net cash position of -920.94 billion.

Cash & Cash Equivalents	353.83B
Total Debt	1.27T
Net Cash	-920.94B
Net Cash Per Share	n/a
Equity (Book Value)	1.85T
Book Value Per Share	324.64
Working Capital	192.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 285.80 billion and capital expenditures -56.57 billion, giving a free cash flow of 229.22 billion.

Operating Cash Flow	285.80B
Capital Expenditures	-56.57B
Free Cash Flow	229.22B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.42%, with operating and profit margins of 26.33% and 12.62%.

Gross Margin	74.42%
Operating Margin	26.33%
Pretax Margin	11.82%
Profit Margin	12.62%
EBITDA Margin	37.34%
EBIT Margin	26.33%
FCF Margin	17.96%

Dividends & Yields

This stock pays an annual dividend of 33.26, which amounts to a dividend yield of 7.37%.

Dividend Per Share	33.26
Dividend Yield	7.37%
Dividend Growth (YoY)	17.12%
Years of Dividend Growth	1
Payout Ratio	121.49%
Buyback Yield	-0.97%
Shareholder Yield	6.68%
Earnings Yield	6.25%
FCF Yield	8.89%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.22. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	n/a